Compounds > cromakalim
Page last updated: 2024-08-25

cromakalim and 293b cpd

cromakalim has been researched along with 293b cpd in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baró, I; Charpentier, F; Escande, D; Kunzelmann, K; Loussouarn, G; Mohammad-Panah, R1

Other Studies

1 other study(ies) available for cromakalim and 293b cpd

ArticleYear
KvLQT1 potassium channel but not IsK is the molecular target for trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl- chromane.
    Molecular pharmacology, 1997, Volume: 52, Issue:6

    Topics: Animals; Binding Sites; Chromans; COS Cells; Cromakalim; Kinetics; Long QT Syndrome; Potassium; Potassium Channel Blockers; Potassium Channels; Sulfonamides

1997